ArticleLeukemia & lymphoma2014

Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).

Kristen Ganjoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.